tiprankstipranks
Oruka Therapeutics (DE:HQ1)
FRANKFURT:HQ1

Compare Oruka Therapeutics (HQ1) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Oruka Therapeutics
€53.00
€2.52B
-13.11
728.13%
13 Buy
0 Hold
0 Sell
Strong Buy
Verastem
$5.31
$466.40M
-4.89
17.48%
7 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$70.10
$2.02B
-101.81
331.65%
9 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$5.17
$931.05M
-12.74
213.33%
9 Buy
0 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$16.10
$1.40B
-13.39
372.14%
10 Buy
1 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$21.12
$1.38B
-6.67
108.08%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:HQ1
Oruka Therapeutics
53.00
46.35
696.99%
VSTM
Verastem
5.31
0.53
11.09%
ANAB
AnaptysBio
70.10
52.24
292.50%
CMPX
Compass Therapeutics
5.17
3.45
200.58%
OLMA
Olema Pharmaceuticals
16.10
12.04
296.55%
BCAX
Bicara Therapeutics Inc.
21.12
9.74
85.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts